🔎︎
The FDA's clearance of Dexcom's Stelo continuous glucose monitor for children ages 2 and older, without a prescription, creates an access pathway outside traditional coverage channels, according to reporting by Lauren Chan at STAT News. The decision extends over-the-counter monitoring, previously limited to adults, to a pediatric population that includes children with type 2 diabetes managed with oral medication and children without diabetes whose families are interested in lifestyle data.
For managed care, the clearance is relevant because prescription CGMs are typically indicated for patients who require insulin therapy, and insurance coverage often follows that indication. Children with prediabetes or type 2 diabetes who are not using insulin may fall outside covered benefits, making out-of-pocket costs a potential barrier. Kristen Nadeau, a pediatric endocrinologist at Children's Hospital Colorado, told STAT that an over-the-counter option could broaden access for underserved patients who may benefit from monitoring before insulin becomes necessary. Stelo is priced at $99 per month for two 15-day sensors, with a free accompanying application.
The article also describes clinical questions that may affect utilization. Because prescription-free devices can be used by children without diabetes or elevated glucose, and because normative pediatric glucose ranges are not yet well defined, interpreting the resulting data may be difficult without clinician involvement. Nadeau noted a shortage of reference data on typical blood sugar ranges in children, a gap that the ongoing DISCOVERY trial aims to address by tracking roughly 3,600 children ages 8 to 15 at elevated risk of diabetes.
Several clinicians interviewed raised concerns that continuous data could encourage restrictive feeding behaviors or contribute to disordered eating, particularly when families lack guidance on interpretation. The FDA's notice advises that patients with a history of eating disorders consult a health care provider before use, and clinicians quoted in the article recommended provider conversations about family goals before adoption. Dexcom's current app materials address adult users, and the company did not detail plans for pediatric-specific resources.
